Immunotherapy of multiple myeloma: the start of a long and tortuous journey.

Immunotherapy of multiple myeloma: the start of a long and tortuous journey. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Immunotherapy of multiple myeloma: the start of a long and tortuous journey. Abstract Text:

Simon J Harrison,Gordon Cook,Robert J B Nibbs,H Miles Prince,

The field of tumor immunotherapy is still in its infancy. It is becoming clear that the human immune response is the result of highly complex, continuously evolving interactions between cells of the adaptive and innate arms of the immune system, the internal and external environments, and normal and abnormal cells (e.g., myeloma plasma cells). Despite the considerable advances in our knowledge over the past 30 years, we have still only scratched the surface of the immune system's interaction with malignant diseases such as myeloma and to date, this has not translated into significantly better outcomes for patients with this disease. This review will summarize our current knowledge of the fundamental immunology of myeloma, review immunotherapy trials reported to date and discuss whether, in light of the current information, immunotherapy of multiple myeloma is an achievable goal.

Immunotherapy of multiple myeloma: the start of a long and tortuous journey. Publishing Authors By Initials

SJ Harrison,G Cook,RJ Nibbs,HM Prince,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Immunotherapy of multiple myeloma: the start of a long and tortuous journey. Journal Published:

PUBLICATION TYPE: Review

Journal: Expert review of anticancer therapy

VOLUME: 6

Page Numbers: 1769-85

Journal Abbreviation: Expert Rev Anticancer Ther

ISSN: 1744-8328

DAY: 5

MONTH: Dec

YEAR: 2006

Immunotherapy of multiple myeloma: the start of a long and tortuous journey. Information

Number of References: 198

LANGUAGE: eng

NlmUniqueID: 101123358

Immunotherapy of multiple myeloma: the start of a long and tortuous journey. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Immunotherapy of multiple myeloma: the start of a long and tortuous journey. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Immunotherapy of multiple myeloma: the start of a long and tortuous journey.

AFFILIATION: DHMO, Peter MacCallum Cancer Centre and Locked Bag 1, A'becket Street, Melbourne, Victoria 8006, Australia. simonharrison@doctors.org.uk

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Expert Rev Anticancer Ther

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Immunotherapy of multiple myeloma: the start of a long and tortuous journey Related Publications

• A new satellite technology for tracking the movements of atlantic bluefin tuna.
• A role for Tbx2 in the regulation of the alpha2(1) collagen gene in human fibroblasts.
• An advance in colour photomicrography of the living eye.
• Automatic 3D tracking of cardiac material markers using slice-following and harmonic-phase MRI.
• Bone mass in young women is dependent on lean body mass.
• Comparison of speech production in upright and supine position.
• Consequences of Hoxb1 duplication in teleost fish.
• Cortical surface alignment using geometry driven multispectral optical flow.
• Epigenetic targets in hematological malignancies: combination therapies with HDACis and demethylating agents.
• Fatty acids ofLindera umbellata and other Lauraceae seed oils.
• Immunostimulatory properties of the emerging pathogen Stenotrophomonas maltophilia.
• Immunotherapy of multiple myeloma: the start of a long and tortuous journey.
• Is there replacement for percentage stenosis in characterizing occlusive vascular disease?
• Markers of inflammation and cognitive decline in an African-Caribbean population.
• Multi-slice three-dimensional myocardial strain tensor quantification using zHARP.
• Opportunistic infections in lung disease: Pseudomonas infections in cystic fibrosis.
• Origin of the zebrafish endocrine and exocrine pancreas.
• Pathways to homelessness among older people in Rio de Janeiro, Brazil.
• Prevalence of depressive symptoms and syndromes in later life in ten European countries: the SHARE study.
• Real-time monitoring of cardiac regional function using fastHARP MRI and region-of-interest reconstruction.
• Safety and efficacy of combining ATRA with G-CSF in HSPC mobilization; a pilot study in multiple myeloma and non-Hodgkin's lymphoma patients.
• Staphylococcus aureus protein A activates TACE through EGFR-dependent signaling.
• Successful treatment of Behçet's disease with lenalidomide.
• Tea drinking is associated with benefits on bone density in older women.
• Tea intake is inversely related to blood pressure in older women.
• Toward optimal matching for 3D reconstruction of brachytherapy seeds.
• Treatment of primary cutaneous follicular centre lymphoma with rituximab: A report of two cases.
• ZHARP: three-dimensional motion tracking from a single image plane.
• Zebrafish Hoxb1a regulates multiple downstream genes including prickle1b.
• [Stress and prevention in the recurrence of coronary heart disease.]